Filana Therapeutics, Inc. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38ad9aef-a446-4cb5-b340-e0883651dd20/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-91.0M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-007962 |
| FY 2024 | $-24.3M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-005919 |
| FY 2023 | $-97.2M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-005894 |
| FY 2022 | $-76.2M | 2022-01-01 – 2022-12-31 | evidence 0001069530-23-000009 |
| FY 2021 | $-32.4M | 2021-01-01 – 2021-12-31 | evidence 0001069530-22-000011 |
| FY 2020 | $-6.3M | 2020-01-01 – 2020-12-31 | evidence 0001069530-21-000020 |
| FY 2019 | $-4.6M | 2019-01-01 – 2019-12-31 | evidence 0001069530-20-000009 |
| FY 2018 | $-6.6M | 2018-01-01 – 2018-12-31 | evidence 0001069530-19-000019 |
| FY 2017 | $-11.9M | 2017-01-01 – 2017-12-31 | evidence 0001069530-18-000004 |
| FY 2016 | $-14.8M | 2016-01-01 – 2016-12-31 | evidence 0001069530-17-000008 |
| FY 2015 | $-14.1M | 2015-01-01 – 2015-12-31 | evidence 0001069530-16-000052 |
| FY 2014 | $-12.4M | 2014-01-01 – 2014-12-31 | evidence 0001069530-15-000003 |
| FY 2013 | $31.5M | 2013-01-01 – 2013-12-31 | evidence 0001069530-14-000004 |
| FY 2012 | $-3.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-046147 |
| FY 2011 | $-2.6M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-049361 |
| FY 2010 | $-12.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-049361 |
| FY 2009 | $-3.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-049361 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Filana Therapeutics, Inc. — all facts · Revenue · Operating Income